203 related articles for article (PubMed ID: 37771778)
21. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
[TBL] [Abstract][Full Text] [Related]
22. NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease.
Colombo G; Caviglia GP; Ravera A; Tribocco E; Frara S; Rosso C; Travelli C; Genazzani AA; Ribaldone DG
Front Med (Lausanne); 2023; 10():1116862. PubMed ID: 36817780
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
[TBL] [Abstract][Full Text] [Related]
24. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.
Kraus D; Reckenbeil J; Veit N; Kuerpig S; Meisenheimer M; Beier I; Stark H; Winter J; Probstmeier R
Cell Oncol (Dordr); 2018 Oct; 41(5):485-494. PubMed ID: 29949049
[TBL] [Abstract][Full Text] [Related]
25. Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy.
Wang L; Liu M; Zu Y; Yao H; Wu C; Zhang R; Ma W; Lu H; Xi S; Liu Y; Hua L; Wang G; Tang Y
Eur J Med Chem; 2022 Jun; 236():114260. PubMed ID: 35385807
[TBL] [Abstract][Full Text] [Related]
26. Advances in NAD-Lowering Agents for Cancer Treatment.
Ghanem MS; Monacelli F; Nencioni A
Nutrients; 2021 May; 13(5):. PubMed ID: 34068917
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy.
LoCoco PM; Risinger AL; Smith HR; Chavera TS; Berg KA; Clarke WP
Elife; 2017 Nov; 6():. PubMed ID: 29125463
[TBL] [Abstract][Full Text] [Related]
28. The NAD(+) salvage pathway modulates cancer cell viability via p73.
Sharif T; Ahn DG; Liu RZ; Pringle E; Martell E; Dai C; Nunokawa A; Kwak M; Clements D; Murphy JP; Dean C; Marcato P; McCormick C; Godbout R; Gujar SA; Lee PW
Cell Death Differ; 2016 Apr; 23(4):669-80. PubMed ID: 26586573
[TBL] [Abstract][Full Text] [Related]
29. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling.
Chowdhry S; Zanca C; Rajkumar U; Koga T; Diao Y; Raviram R; Liu F; Turner K; Yang H; Brunk E; Bi J; Furnari F; Bafna V; Ren B; Mischel PS
Nature; 2019 May; 569(7757):570-575. PubMed ID: 31019297
[TBL] [Abstract][Full Text] [Related]
30. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells.
Hara N; Yamada K; Shibata T; Osago H; Hashimoto T; Tsuchiya M
J Biol Chem; 2007 Aug; 282(34):24574-82. PubMed ID: 17604275
[TBL] [Abstract][Full Text] [Related]
31. Targeting the NAD
Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway.
Grohmann T; Penke M; Petzold-Quinque S; Schuster S; Richter S; Kiess W; Garten A
Leuk Res; 2018 Jun; 69():39-46. PubMed ID: 29653431
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological bypass of NAD
Liu HW; Smith CB; Schmidt MS; Cambronne XA; Cohen MS; Migaud ME; Brenner C; Goodman RH
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10654-10659. PubMed ID: 30257945
[TBL] [Abstract][Full Text] [Related]
34. Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Xiao Y; Elkins K; Durieux JK; Lee L; Oeh J; Yang LX; Liang X; DelNagro C; Tremayne J; Kwong M; Liederer BM; Jackson PK; Belmont LD; Sampath D; O'Brien T
Neoplasia; 2013 Oct; 15(10):1151-60. PubMed ID: 24204194
[TBL] [Abstract][Full Text] [Related]
35. Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.
Yao H; Liu M; Wang L; Zu Y; Wu C; Li C; Zhang R; Lu H; Li F; Xi S; Chen S; Gu X; Liu T; Cai J; Wang S; Yang M; Xing GG; Xiong W; Hua L; Tang Y; Wang G
Cell Res; 2022 Jun; 32(6):570-584. PubMed ID: 35459935
[TBL] [Abstract][Full Text] [Related]
36. Ability of metformin to deplete NAD+ contributes to cancer cell susceptibility to metformin cytotoxicity and is dependent on NAMPT expression.
Zhuang Y; Haugrud AB; Schaefer MA; Messerli SM; Miskimins WK
Front Oncol; 2023; 13():1225220. PubMed ID: 37583931
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of nicotinamide phosphoribosyltransferase protects against acute pancreatitis via modulating macrophage polarization and its related metabolites.
He Y; Dai J; Niu M; Li B; Chen C; Jiang M; Wu Z; Bao J; Zhang X; Li L; Husain SZ; Hu G; Wen L
Pancreatology; 2021 Aug; 21(5):870-883. PubMed ID: 33810973
[TBL] [Abstract][Full Text] [Related]
39. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
[TBL] [Abstract][Full Text] [Related]
40. NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.
Audrito V; Messana VG; Deaglio S
Front Oncol; 2020; 10():358. PubMed ID: 32266141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
